What pharmacists are saying about the coronavirus

While pharmacists are divided on whether they consider the coronavirus to be a serious health threat in the United States, most say their customers are highly concerned, according to a survey conducted by the National Community Pharmacists Association.

Advertisement

Of the 124 pharmacists included in the survey, 32 percent said they considered coronavirus a significant U.S. public health threat, 42 percent did not, and 26 percent said they’re unsure. 

Fifty-four percent said their patients have told them they are very worried about the coronavirus. 

Sixty-three percent of local pharmacists said their customers are buying surgical masks in response to the perceived threat, and 96 percent said their pharmacy is selling masks faster than they can restock them. They also reported shortages of hand sanitizers, surface sanitizers and gloves.

“Patients are on edge, and they’re preparing,” Brian Caswell, president of the pharmacists association, said.

Local pharmacists are often the most accessible healthcare providers in most communities, Mr. Caswell said.

Find the full survey here

More articles on pharmacy:
How 4 hospital pharmacies are improving operations
The 10 most-valued pharma brands in the world
Merck to create spinoff women’s health company, focus on Keytruda

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.